Inhibiting CHK2 improves oocyte quality and reduces ovarian inflammation in aged mice
A multi-omic analysis shows that defective luteal resolution and CHK2-driven inflammation drive ovarian aging, but drug inhibition restores oocyte maturation.
bioRxiv · Yang L et al. · Paper published 1 Oct 2026
In a new preprint, researchers analyzed ovaries from young and reproductively aged mice after synchronized ovulation. They found that aged mouse ovaries accumulated luteal cells with increased steroidogenic, antigen presentation, and inflammatory gene expression. Overall DNA methylation remained globally preserved, though focal changes occurred at regulatory regions. Protein profiling showed higher levels of checkpoint kinase 2 (CHK2), a DNA damage response protein linked to natural menopause timing. CHK2 and DNA damage markers were elevated in both aged mice and aged human ovarian somatic cells. Transient pharmacological inhibition of CHK2 in aged mice increased the proportion of mature oocytes and blastocyst formation, while reversing inflammatory signatures in granulosa cells.
Why it matters
The findings show that ovarian aging involves defective luteal clearance and a reversible inflammatory state. This indicates that age-related reproductive decline can be pharmacologically modified by targeting DNA damage response proteins.
Caveats
Most findings and all interventional outcomes come from mice, so efficacy in people remains unproven. In addition, this work is a preprint and has not yet been peer-reviewed.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Multi-omic profiling reveals impaired luteal resolution and CHK2-regulated inflammation in ovarian aging
Yang L, Sun Z, Luo X et al.
bioRxiv · 1 Oct 2026 · Preprint, not yet peer-reviewed
- Relevance
- Core geroscience
- News value
- Important
- Evidence
- Animals
- Status
- Preprint
More on Inflammaging
See allCranial bone marrow monocytes drive brain injury inflammation and respond to fenofibrate
Targeting PPARα deficiency in cranial bone marrow monocytes improved cognitive function and reduced neurodegeneration markers in older patients with chronic brain injury.
Science translational medicine · Lu Z et al.
Somatic blood mutations associate with accelerated frailty and functional decline in humans
In a preprint analyzing over 730,000 adults, researchers linked clonal hematopoiesis to faster physical decline mediated by T-cell changes.
medRxiv · Zhao K et al.
Impaired glymphatic clearance links inflammation to accelerated brain aging in schizophrenia
Neuroimaging and post-mortem transcriptomics connect disrupted astrocytic aquaporin-4 polarization and blood-brain barrier breakdown to increased epigenetic and brain age.
bioRxiv · Tan X et al.
ASXL1 mutations in clonal hematopoiesis accelerate aortic valve calcification
Large human cohort data and cell experiments show that ASXL1-driven clonal hematopoiesis worsens aortic valve hemodynamics and promotes calcification through inflammatory signaling.
medRxiv · Small A et al.
Loss of SATB1 alters 3D genome architecture in aged mouse T cells
Declining levels of the chromatin organizer SATB1 disrupt genomic boundaries and drive inflammatory gene activation in naive CD4+ T cells.
Science advances · Wang B et al.